The DOI matches its Crossref record.
The Health and Economic Burden of Genital Warts in a Set of Private Health Plans in the United States
Abstract
We estimated the prevalence of and costs associated with genital warts among privately insured individuals from the perspective of a private health plan in the United States. Health care claims data were derived from a sample of 3,664,686 privately insured individuals. The database was limited to cases of disease for which an insurance claim was generated, with costs reflecting inpatient, outpatient, and pharmacy payments from all sources. We identified 5095 cases of genital warts (1.7 cases per 1000 person-years) billed through the health plans during 2000. The prevalences of and health plan costs associated with genital warts were highest among women aged 20-24 years (6.2 cases and $1692 in costs per 1000 person-years) and men aged 25-29 years (5.0 cases and $1717 in costs per 1000 person-years). On average, individual episodes of care for genital warts involved 3.1 physician visits and incurred costs of $436. These are the first age- and sex-specific estimates of the prevalence and cost of genital warts for a US health plan.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R. (2007) · PsycEXTRA Dataset · doi:10.1037/e601292007-001 · Cited by 1,882
Paavonen, J., Naud, P., Salmerón, J., Wheeler, C., Chow, S.-N., Apter, D., Kitchener, H., Castellsague, X., Teixeira, J., Skinner, Sr., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61248-4 · Cited by 1,655
Global Burden of Human Papillomavirus and Related Diseases
Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., Lortet-Tieulent, J., Bruni, L., Vignat, J., Ferlay, J., Bray, F., Plummer, M., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.07.055 · Cited by 1,642
Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
Giuliano, A. R., Palefsky, J. M., Goldstone, S., Moreira, E. D., Penny, M. E., Aranda, C., Vardas, E., Moi, H., Jessen, H., Hillman, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0909537 · Cited by 1,146
Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease
Lacey, C. J. N., Lowndes, C. M., & Shah, K. V. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.015 · Cited by 535
Model for Assessing Human Papillomavirus Vaccination Strategies
Elbasha, E. H., Dasbach, E. J., & Insinga, R. P. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1301.060438 · Cited by 491
Self-citationBlock, S. L., Nolan, T., Sattler, C., Barr, E., Giacoletti, K. E. D., Marchant, C. D., Castellsagué, X., Rusche, S. A., Lukac, S., Bryan, J. T., et al. (2006) · Pediatrics · doi:10.1542/peds.2006-0461 · Cited by 484
Systematic review of the incidence and prevalence of genital warts
Patel, H., Wagner, M., Singhal, P., & Kothari, S. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-39 · Cited by 428
The FUTURE I/II Study Group (2010) · BMJ · doi:10.1136/bmj.c3493 · Cited by 415
Giuliano, A. R., Tortolero-Luna, G., Ferrer, E., Burchell, A. N., de Sanjose, S., Kjaer, S. K., Muñoz, N., Schiffman, M., & Bosch, F. X. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.021 · Cited by 409
Donovan, B., Franklin, N., Guy, R., Grulich, A. E., Regan, D. G., Ali, H., Wand, H., & Fairley, C. K. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70225-5 · Cited by 380
Health and Economic Implications of HPV Vaccination in the United States
Kim, J. J., & Goldie, S. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa0707052 · Cited by 365
Quadrivalent Human Papillomavirus Vaccine
Gellin, B., Modlin, J. F., Barr, E., & Tamms, G. (2007) · Clinical Infectious Diseases · doi:10.1086/520654 · Cited by 330
Joura, E. A., Garland, S. M., Paavonen, J., Ferris, D. G., Perez, G., Ault, K. A., Huh, W. K., Sings, H. L., James, M. K., Haupt, R. M., et al. (2012) · BMJ · doi:10.1136/bmj.e1401 · Cited by 316
Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer
Chelimo, C., Wouldes, T. A., Cameron, L. D., & Elwood, J. M. (2013) · Journal of Infection · doi:10.1016/j.jinf.2012.10.024 · Cited by 303
Reisinger, K. S., Block, S. L., Lazcano-Ponce, E., Samakoses, R., Esser, M. T., Erick, J., Puchalski, D., Giacoletti, K. E. D., Sings, H. L., Lukac, S., et al. (2007) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000253970.29190.5a · Cited by 296
Cost-of-Illness Studies: A Review of Current Methods
Akobundu, E., Ju, J., Blatt, L., & Mullins, C. D. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624090-00005 · Cited by 279
Epidemiology and Natural History of Human Papillomavirus Infections in the Female Genital Tract
Ault, K. A. (2006) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/idog/2006/40470 · Cited by 269
Metadata
- Authors
- Insinga, R. P., Dasbach, E. J., & Myers, E. R.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-06-01
- Volume
- 36
- Issue
- 11
- Pages
- 1397-1403
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2168617662
- Cited by
- 216
- References
- 0
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.